SEC Form 4 · accession 0001093557-16-000448

DEXCOM INC · DXCM

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — SVP, Operations

Period of report

Mar 8, 2016

Accepted (ET)

Mar 10, 2016 · 8:59 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001093557

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1,F2	Mar 8, 2016	A	33,000	$0.001	A	106,334	D
Common Stock^F3,F2	Mar 8, 2016	J	8,333	$66.10	D	98,001	D
Common Stock^F3,F2	Mar 8, 2016	J	13,334	$66.10	D	84,667	D
Common Stock^F3,F4	Mar 8, 2016	J	8,333	$66.10	A	68,599	I	by Trust
Common Stock^F3,F4	Mar 8, 2016	J	13,334	$66.10	A	81,933	I	by Trust

No Table II lines on this filing.

F1Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting over a 36 month period from the date of grant as follows: 1/3 shall vest 12 months from the Grant Date, and the remaining balance shall vest in four equal installments over the following 24 months. Share units represent a contingent right to receive one share of DexCom, Inc. common stock.
F2Included in this number are 84,667 unvested restricted stock units, 33,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019, 26,666 of which were granted on March 8, 2015 and shall vest through March 8, 2018, 16,667 of which were granted on March 8, 2014 and shall vest through March 08, 2017, and 8,334 of which were granted on March 11, 2013 and shall vest through March 11, 2016.
F3Shares were transferred from direct ownership to ownership under the Moy Family Trust upon vesting of previously awarded restricted stock units.
F4Shares are held by the Moy Family Trust U/A/D 12/09/2013, with respect to which the reporting person is a trustee.